Home > Investors
Investor Relations Home
E-mail Page Print Page RSS Feeds E-mail Alerts IR Contacts Financial Tear Sheet 
About Us
Download Documentation 2016 Guidance Worksheet
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation Update on ABP-700
Download Documentation ALN-PCSsc Phase 1 Clinical Results Presentation
Download Documentation ABP-700 & MDCO-216 Conference Call Presentation
Corporate Profile
The Medicines Company provides medical solutions to improve health outcomes for patients in acute and intensive care hospitals worldwide. These solutions comprise medicines and knowledge that directly impact the survival and well-being of critically ill patients.
Stock Quote
MDCO (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$37.67
Change (%) Stock is Up 0.45 (1.21%)
Volume396,779
Data as of 05/27/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News
DateTitle 
05/26/16The Medicines Company Announces Completion of Patient Enrollment in Phase 3 TANGO 1 Study of CARBAVANCE® (meropenem-vaborbactam) for Treatment of Complicated Urinary Tract Infections (cUTI)
Patient enrollment completed ahead of schedule PARSIPPANY, N.J.--(BUSINESS WIRE)--May 26, 2016-- The Medicines Company (NASDAQ:MDCO) has announced the completion of patient enrollment in the Phase 3 TANGO 1 study of CARBAVANCE® (meropenem-vaborbactam), an investigational agent being developed for the treatment of complicated urinary tract infections (cUTI). TANGO 1 was initiated in the fourth quarter of 2014 under a cost-share agreement ... 
Printer Friendly Version
05/25/16The Medicines Company to Present at Two Upcoming Investor Conferences
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 25, 2016-- The Medicines Company (NASDAQ:MDCO) today announced that the company is scheduled to make presentations at the following June investor conferences: Jefferies 2016 Healthcare Conference – New York City, Tuesday, June 7 at 9:00 a.m. EDT Goldman Sachs 37th Annual Global Healthcare Conference 2016 – Ranchos Palos Verdes, Calif., Wednesday, June 8 at 4:00 p.m. PDT The pres... 
Printer Friendly Version
05/16/16The Medicines Company Appoints Tony Kingsley as President and Chief Operating Officer
PARSIPPANY, N.J.--(BUSINESS WIRE)--May 16, 2016-- The Medicines Company (NASDAQ:MDCO) has announced the appointment of Tony Kingsley as President and Chief Operating Officer. Mr. Kingsley will help oversee the day-to-day operations of the company and will lead the company’s commercial activities. Before joining The Medicines Company, Mr. Kingsley was Executive Vice President, Global Commercial Operations at Biogen, where he oversaw the lau... 
Printer Friendly Version
05/09/16The Medicines Company Reports First-Quarter 2016 Business and Financial Results
Four potential blockbuster R&D programs advancing toward key data disclosures in 2016 The announced divestiture of non-core cardiovascular assets to Chiesi Farmaceutici S.p.A. will sharpen strategic focus and significantly strengthen financial position to drive further development of R&D programs without diluting shareholders Newly launched hospital products being introduced in multiple geographic and ... 
Printer Friendly Version
Upcoming Events
DateTitle
06/07/16 9:00 a.m. ET
The Medicines Company at Jefferies 2016 Healthcare Conference
LocationNew York, NY
06/08/16 4:00 p.m. PT
The Medicines Company at Goldman Sachs 37th Annual Global Healthcare Conference 2016
LocationRanchos Palos Verdes, CA

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.